XML 60 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
Merck GHI Financing (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 06, 2017
Jul. 31, 2015
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Dec. 31, 2015
Jun. 28, 2017
Common Stock And Note Purchase Agreement [Line Items]                  
Proceeds from issuance of common stock, net of issuance costs         $ 3,426,050 $ 124 $ 4,405,973 $ 17,366,620  
Adjustments to additional paid in capital, stock issued, issuance costs               $ 58,566  
Fair value adjustment of warrants     $ (9,739,500,000) $ 0 (12,413,900,000) $ 0      
Amended And Restated M G H I F Financing Agreement [Member]                  
Common Stock And Note Purchase Agreement [Line Items]                  
Debt instrument, interest rate, stated percentage 10.00%                
Debt instrument, extended maturity date Jul. 14, 2018                
Warrant expiration period 5 years                
Issuance of common stock warrants to purchase 13,119                
Warrants first exercisable period after issuance date 6 months                
Class of warrant or right, exercise price of warrants or rights $ 19.50                
Percentage of warrant exercise price on common stock closing price on date of issuance 110.00%                
Estimated fair value of debt     $ 1,000,000   1,000,000   $ 1,000,000    
Amended And Restated M G H I F Financing Agreement [Member] | Black Scholes Model [Member]                  
Common Stock And Note Purchase Agreement [Line Items]                  
Fair value adjustment of warrants         $ 100,000        
M G H I F Financing Agreement [Member]                  
Common Stock And Note Purchase Agreement [Line Items]                  
Stock issued during period, shares, new issues   45,454              
Shares issued, price per share   $ 110.00              
Proceeds from issuance of common stock, net of issuance costs   $ 5,000,000              
Debt instrument, interest rate, stated percentage   8.00%              
Debt instrument, face amount   $ 1,000,000              
Fees related to common stock and debt transaction   5,000,000,000              
Deferred debt issuance costs   800,000,000              
Adjustments to additional paid in capital, stock issued, issuance costs   $ 4,200,000,000              
Second Amended And Restated Merck Ghi Financing Agreement [Member]                  
Common Stock And Note Purchase Agreement [Line Items]                  
Debt instrument, interest rate, stated percentage                 10.00%
Debt instrument, extended maturity date         Jul. 14, 2018